# Health innovations and economic shifts are making waves globally.

*biotech, business · news · 2026-05-05 · Devdiscourse*

## Key points

- Mirum Pharmaceuticals' rare liver disease drug achieved a key milestone in a mid-stage clinical study.
- Swiss biotechs saw a 38% increase in private investment compared to 2024 amid tough markets.
- GMR Solutions targets a $5 billion valuation with a planned IPO in the United States.
- A hantavirus outbreak on a cruise ship led to three passenger deaths.

Health innovations and economic shifts are making waves globally. Mirum Pharmaceuticals has reached a significant milestone with its rare liver disease drug in a mid-stage study. Meanwhile, Swiss biotechs are benefiting from a pivot towards private funding amid challenging capital markets, revealing a 38% increase in private investment compared to 2024. In investment news, multiple pharmaceutical and biotech companies are preparing for substantial IPOs. Emergency medical services provider GMR Solutions eyes a $5 billion valuation in the U.S., while China's Impact Therapeutics and Boston-based Odyssey Therapeutics are also launching IPOs in Hong Kong and the U.S. respectively, signaling strong investor interest. On a critical note, health alerts have arisen with a hantavirus outbreak on a cruise ship resulting in three deaths. Additionally, legal tussles over mail-order access to mifepristone continue in the U.S., reflecting the ongoing debates surrounding reproductive health policies. (With inputs from agencies.)

**Companies:** Mirum Pharmaceuticals, GMR Solutions, Impact Therapeutics, Odyssey Therapeutics
**Countries:** United States, China

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3896876-global-health-innovations-and-challenges-from-ipos-to-outbreaks)

---

Canonical: https://newsio.io/n/0c2409c9-78f2-4985-a451-7489ebf64a34/health-innovations-and-economic-shifts-are-making-waves-globally-mirum-pharmaceu
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works